Lawson Health Research Institute has announced the launch of the ORATOR trial. This landmark study is the first trial in the world to compare robotic surgery to radiation for the treatment of oropharyngeal cancer. The study will examine the impact of both treatments on patients’ speech and swallowing function, and quality of life as a first step toward identifying the best treatment for patients.
